Top advances of the year: Melanoma

被引：1
|
作者：
Khattak, Muhammad Adnan [1 ,2 ]
Luke, Jason J. [3 ,4 ]
机构：
[1] Fiona Stanley Hosp, Perth, WA, Australia
[2] Edith Cowan Univ, Perth, WA, Australia
[3] UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[4] Univ Pittsburgh, Pittsburgh, PA USA
来源：
CANCER | 2024年 / 130卷 / 16期
基金：
美国国家卫生研究院;
关键词：
cellular therapy; immunotherapy; melanoma; neoadjuvant; personalized vaccine; tumor-infiltrating lymphocytes; INFILTRATING LYMPHOCYTE THERAPY; OPACIN-NEO; IPILIMUMAB; SURVIVAL; NIVOLUMAB; ADJUVANT; UPDATE;
D O I：
10.1002/cncr.35354
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The field of melanoma therapeutics is moving quickly with the first approval of adoptive cell transfer in solid tumors. Moreover, individualized neoantigen therapies, PRAME-targeting strategies, oncolytic viruses, and more are rapidly emerging.
引用
收藏
页码：2733 / 2738
页数：6
相关论文
共 50 条
  • [41] Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)
    Wei, Alexander Z.
    Chen, Lanyi N.
    Orloff, Marlana
    Ariyan, Charlotte E.
    Asgari, Maryam
    Barker, Christopher A.
    Buchbinder, Elizabeth
    Chandra, Sunandana
    Couts, Kasey
    Frumovitz, Michael M.
    Futreal, Andrew
    Gershenwald, Jeffrey E.
    Hanna, Ehab Y.
    Izar, Benjamin
    Leblanc, Amy K.
    Leitao, Mario M.
    Lipson, Evan J.
    Liu, David
    Mccarter, Martin
    Mcquade, Jennifer L.
    Najjar, Yana
    Rapisuwon, Suthee
    Selig, Sara
    Shoushtari, Alexander N.
    Yeh, Iwei
    Schwartz, Gary K.
    Guo, Jun
    Patel, Sapna P.
    Carvajal, Richard D.
    PIGMENT CELL & MELANOMA RESEARCH, 2023, 36 (06) : 542 - 556
  • [42] Nivolumab and ipilimumab: immunotherapy for treatment of malignant melanoma
    Carreau, Nicole A.
    Pavlick, Anna C.
    FUTURE ONCOLOGY, 2019, 15 (04) : 349 - 358
  • [43] Perioperative therapy of melanoma: Adjuvant or neoadjuvant treatment
    Rutkowski, Piotr
    Mandala, Mario
    EJSO, 2024, 50 (03):
  • [44] Neo-Adjuvant Therapy for Metastatic Melanoma
    Kuijpers, Anke M. J.
    van Akkooi, Alexander C. J.
    CANCERS, 2024, 16 (07)
  • [45] Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)
    Ascierto, Paolo A.
    Puzanov, Igor
    Agarwala, Sanjiv S.
    Blank, Christian
    Carvajal, Richard D.
    Demaria, Sandra
    Dummer, Reinhard
    Ernstoff, Marc
    Ferrone, Soldano
    Fox, Bernard A.
    Gajewski, Thomas F.
    Garbe, Claus
    Hwu, Patrick
    Lo, Roger S.
    Long, Georgina V.
    Luke, Jason J.
    Osman, Iman
    Postow, Michael A.
    Sullivan, Ryan J.
    Taube, Janis M.
    Trinchieri, Giorgio
    Zarour, Hassane M.
    Caraco, Corrado
    Thurin, Magdalena
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [46] Immunotherapy in Melanoma: Recent Advances and Future Directions
    Knight, Andrew
    Karapetyan, Lilit
    Kirkwood, John M.
    CANCERS, 2023, 15 (04)
  • [47] Immunotherapy in melanoma: advances, pitfalls, and future perspectives
    Sorino, Cristina
    Iezzi, Simona
    Ciuffreda, Ludovica
    Falcone, Italia
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
  • [48] Recent Advances in Immunotherapy for the Treatment of Malignant Melanoma
    Tuli, Hardeep Singh
    Sak, Katrin
    Iqubal, Ashif
    Choudhary, Renuka
    Adhikary, Shubham
    Kaur, Ginpreet
    Kumar, Pawan
    Garg, Vivek Kumar
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (29) : 2363 - 2374
  • [49] Advances in the discovery and development of melanoma drug therapies
    Chanda, Monica
    Cohen, Mark S.
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (11) : 1319 - 1347
  • [50] SEOM clinical guideline for the management of malignant melanoma (2017)
    Berrocal, A.
    Arance, A.
    Castellon, V. E.
    de la Cruz, L.
    Espinosa, E.
    Cao, M. G.
    Larriba, J. L. G.
    Marquez-Rodas, I.
    Soria, A.
    Algarra, S. M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01) : 69 - 74
12345